Home | List of Topics | Brain and Nervous System | Movement Disorders (e.g., Parkinson's Disease)
Progressive supranuclear palsy is a movement disorder caused by damage to certain nerve cells in the brain.
Progressive supranuclear palsy is a condition that causes symptoms similar to those of Parkinson's disease.
It involves damage to many cells of the brain. The covering of certain nerve cells (myelin sheath) is destroyed. Entire nerves may be damaged in some areas. The cause of the damage to the brain cells is unknown. The disease gets worse over time (degenerative).
People with this condition have deposits in brain tissues that look like those found in patients with Alzheimer's disease. There is a loss of tissue in most areas of the brain.
The disorder is most often seen in people over 60 years old, and is somewhat more common in men.
An exam of the nervous system (neurological examination) may show:
The health care provider may do tests to rule out other diseases. Magnetic resonance imaging (MRI) might show shrinking of the brainstem.
The goal of treatment is to control symptoms. There is no known cure for progressive supranuclear palsy.
Levodopa and drugs that block the action of a nervous system chemical called acetylcholine (anticholinergic medications) may temporarily reduce symptoms. These medications are not as effective as they are for Parkinson's disease, however.
Many people with this condition will need around-the-clock care and monitoring as they lose brain functions.
Treatment sometimes can reduce symptoms temporarily, but the condition will get worse. Brain function will decline over time. Death commonly occurs in 5 to 7 years.
Call your health care provider if you often fall, and if you have a stiff neck/body and vision problems.
Also, call if a loved one has been diagnosed with progressive supranuclear palsy and the condition has declined so much that you can no longer care for the person at home.
Goetz CG. Goetz: Textbook of Clinical Neurology. 3rd ed. Philadelphia, Pa: Saunders; 2007.
Review Date:2/6/2008
Reviewed By:Daniel Kantor, MD, Director of the Comprehensive MS Center, Neuroscience Institute, University of Florida Health Science Center, Jacksonville, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.